ERIC STORCH to Implosive Therapy
This is a "connection" page, showing publications ERIC STORCH has written about Implosive Therapy.
Connection Strength
10.770
-
High intensity approaches to exposure and response prevention for obsessive-compulsive disorder. Behav Brain Res. 2025 03 12; 481:115427.
Score: 0.774
-
Preferences for Justice-Based Exposure and Response Prevention Among Individuals With Identity-Related Obsessive-Compulsive Disorder. Behav Ther. 2025 Jul; 56(4):753-767.
Score: 0.769
-
Potential for Harm in the Treatment of Pediatric Obsessive-Compulsive Disorder: Pitfalls and Best Practices. Res Child Adolesc Psychopathol. 2025 05; 53(5):729-745.
Score: 0.762
-
Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder. Psychiatry Res. 2021 01; 295:113597.
Score: 0.582
-
Irritability in Children and Adolescents With OCD. Behav Ther. 2021 07; 52(4):883-896.
Score: 0.580
-
COVID-19 and OCD: Potential impact of exposure and response prevention therapy. J Anxiety Disord. 2020 12; 76:102314.
Score: 0.574
-
Conducting exposure and response prevention treatment for contamination fears during COVID-19: The behavioral immune system impact on clinician approaches to treatment. J Anxiety Disord. 2020 08; 74:102270.
Score: 0.565
-
Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences. Depress Anxiety. 2020 05; 37(5):418-428.
Score: 0.551
-
A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder. Depress Anxiety. 2020 05; 37(5):407-417.
Score: 0.543
-
Chinese Therapists' Beliefs About Exposure Therapy for Anxiety and Obsessive-Compulsive Disorders. J Psychiatr Pract. 2019 05; 25(3):179-185.
Score: 0.521
-
Defining Treatment Outcomes in Pediatric Obsessive-Compulsive Disorder Using a Self-Report Scale. Behav Ther. 2019 03; 50(2):314-324.
Score: 0.491
-
Impact of the 2016 US presidential election on OCD symptom presentation: A case illustration. J Clin Psychol. 2018 05; 74(5):750-754.
Score: 0.482
-
A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission. J Clin Psychiatry. 2017 02; 78(2):196-206.
Score: 0.446
-
Outcome of multidisciplinary, CBT-focused treatment for pediatric OCD. Gen Hosp Psychiatry. 2016 Sep-Oct; 42:7-8.
Score: 0.426
-
Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: a pilot randomized controlled trial. Behav Res Ther. 2014 May; 56:30-8.
Score: 0.365
-
Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy. Depress Anxiety. 2013 Aug; 30(8):723-31.
Score: 0.346
-
When exposures go wrong: troubleshooting guidelines for managing difficult scenarios that arise in exposure-based treatment for obsessive-compulsive disorder. Am J Psychother. 2010; 64(1):39-53.
Score: 0.273
-
Homework adherence in exposure-based CBT for youth with obsessive-compulsive disorder: Clinical outcomes and predictors across treatment. Behav Res Ther. 2026 07; 202:105050.
Score: 0.211
-
Childhood Anxiety Disorders. Psychiatr Clin North Am. 2024 12; 47(4):723-739.
Score: 0.185
-
A protocol for a randomized controlled trial of exposure and response prevention for veterans with obsessive compulsive disorder. Contemp Clin Trials. 2024 03; 138:107445.
Score: 0.181
-
Longitudinal trajectory and predictors of change in family accommodation during exposure therapy for pediatric OCD. J Anxiety Disord. 2021 10; 83:102463.
Score: 0.153
-
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
Score: 0.134
-
Open Trial of Modular Cognitive-Behavioral Therapy in the Treatment of Anxiety Among Late Adolescents with Autism Spectrum Disorder. Child Psychiatry Hum Dev. 2019 02; 50(1):27-34.
Score: 0.128
-
D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents. Brain Behav. 2018 06; 8(6):e00984.
Score: 0.122
-
Intensive family exposure-based cognitive-behavioral treatment for adolescents with anorexia nervosa. Psicothema. 2017 Nov; 29(4):433-439.
Score: 0.118
-
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510.
Score: 0.113
-
A Case Report of Harm-Related Obsessions in Pediatric Obsessive-Compulsive Disorder. J Clin Psychol. 2016 11; 72(11):1120-1128.
Score: 0.109
-
Cognitive-behavioral therapy for 2 youths with misophonia. J Clin Psychiatry. 2015 May; 76(5):573-4.
Score: 0.099
-
Parental involvement in youth anxiety treatment: conceptual bases, controversies, and recommendations for intervention. J Anxiety Disord. 2015 Mar; 30:16-8.
Score: 0.097
-
Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale. J Am Acad Child Adolesc Psychiatry. 2010 Jul; 49(7):708-17.
Score: 0.070